| (11) | Registration Number: | P20140223 (Validated european patent) | |
| (21) | File number: | P20140223T |
| (22) | Date of filing the request: | 11.03.2014 |
| (45) | Patent Publication Date and Gazette Number: | 11.04.2014 |
| (54) | English Title: | DOLUTEGRAVIR PRODRUGS |
| (96) | Number of the European patent application: | EP 09800989.7, 23.07.2009 | |
| (97) | Publication data of the European patent application: | EP 2320908, 18.05.2011, 201120, en | |
| (97) | Publication data of the European patent: | EP 2320908, 25.12.2013, 201352, en | |
| (51) | IPC: | C07D 498/14 (2006.01) |
| | | A61K 31/535 (2006.01) |
| | | A61P 31/18 (2006.01) |
| (73) | Holder(s): | | 1. | VIIV Healthcare Company, Five Moore Drive, Research Triangle Park, NC 27709, US |
| |
| | | | 2. | Shionogi & Co., Ltd., 1-8, Doshomachi 3-chome, Chuo-ku Osaka-shi, 541-0045 Osaka, JP |
| |
| (72) | Inventor(s): | | 1. | Brian Alvin Johns, c/o Glaxosmithkline Corporate Intellectual Property Dept., Five Moore Drive, P.O. Box 13398, Research Triangle Park, NC 27709, US |
| |
| | | 2. | Jason Gordon Weatherhead, c/o Glaxosmithkline Corporate Intellectual Property Dept., Five Moore Drive, P.O. Box 13398, Research Triangle Park, NC 27709, US |
| |
| | | 3. | Yasunori Aoyama, c/o Shionogi & Co., Ltd Intellectual Property Department 12-4, Sagisu 5-chome, Fukushima-ku, 553-0002 Osaka, JP |
| |
| | | 4. | Toshikazu Hakogi, c/o Shionogi & Co., Ltd Intellectual Property Department 12-4, Sagisu 5-chome, Fukushima-ku, 553-0002 Osaka, JP |
| |
| (74) | Representative: | PETOŠEVIĆ d.o.o.,
Ulica Josipa Račića 2, 10000 Zagreb, HR
|
| (30) | Priority Data: | | (31) | 83612 P | | (32) | 25.07.2008 | | (33) | US |
|
| (86) | PCT Application Number and Date | PCT/US2009051497; 23.07.2009 |
| (87) | PCT Publication Number and Date | WO2010011812; 28.01.2010 |
| (46) | Publication Date of Translation of a European Patent Claims and the Gazette Number: | 11.04.2014 |
| | Annual fee: | 09.07.2024 for the 16th year | |
|
| |